Publications in OpenAlex of which a co-author is affiliated to this organization
All publications | By field | By subfield
All publications [Next]
| Title | DOI |
|---|---|
| https://doi.org/10.1097/gme.0b013e31824d8f40 | Executive summary of the Stages of Reproductive Aging Workshop + 10 |
| https://doi.org/10.1210/jc.2011-3362 | Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the Unfinished Agenda of Staging Reproductive Aging |
| https://doi.org/10.1097/gme.0000000000000921 | The 2017 hormone therapy position statement of The North American Menopause Society |
| https://doi.org/10.1097/gme.0b013e31824b970a | The 2012 Hormone Therapy Position Statement of The North American Menopause Society |
| https://doi.org/10.3109/13697137.2011.650656 | Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging |
| https://doi.org/10.1016/s0015-0282(01)02909-0 | Executive summary: stages of reproductive aging workshop (STRAW) |
| https://doi.org/10.1210/jc.2009-2509 | Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement |
| https://doi.org/10.1097/gme.0000000000000329 | Genitourinary syndrome of menopause |
| https://doi.org/10.1080/cmt.4.4.267.272 | Executive summary: Stages of Reproductive Aging Workshop (STRAW) |
| https://doi.org/10.1186/1477-7525-3-47 | Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review |
| https://doi.org/10.3109/13697137.2014.946279 | Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society |
| https://doi.org/10.1016/s1470-2045(12)70075-x | Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial |
| https://doi.org/10.1089/152460901753285732 | Stages of Reproductive Aging Workshop (STRAW) |
| https://doi.org/10.1016/j.jsbmb.2005.08.010 | Progesterone and the immunology of pregnancy |
| https://doi.org/10.2147/tcrm.s3552 | The use of calcium and vitamin D in the management of osteoporosis |
| https://doi.org/10.1097/00042192-200111000-00004 | Executive summary: Stages of Reproductive Aging Workshop (STRAW) Park City, Utah, July, 2001 |
| https://doi.org/10.1210/jc.2019-01603 | Global Consensus Position Statement on the Use of Testosterone Therapy for Women |
| https://doi.org/10.1016/j.fertnstert.2012.01.128 | Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging |
| https://doi.org/10.1111/jsm.12686 | Genitourinary Syndrome of Menopause: New Terminology for Vulvovaginal Atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society |
| https://doi.org/10.1097/gme.0b013e31821fc8e0 | The role of soy isoflavones in menopausal health |
| https://doi.org/10.3109/13697139909038088 | The International Menopause menopause-related terminology definitions |
| https://doi.org/10.1097/gme.0000000000001138 | The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review |
| https://doi.org/10.1016/j.phrs.2018.05.015 | Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper |
| https://doi.org/10.1016/j.maturitas.2012.01.013 | Assessment of sexual function of mid-aged Ecuadorian women with the 6-item Female Sexual Function Index |
| https://doi.org/10.1097/gme.0b013e3181d76953 | Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial |
| https://doi.org/10.1080/13697137.2019.1637079 | Global Consensus Position Statement on the Use of Testosterone Therapy for Women |
| https://doi.org/10.1097/gme.0000000000000710 | Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: the Women's Health Initiative |
| https://doi.org/10.1097/gme.0b013e3182227ebd | Patterns and predictors of sexual activity among women in the Hormone Therapy trials of the Women's Health Initiative |
| https://doi.org/10.1097/spv.0b013e31820e5d06 | Risk Factors for Prolapse Development in White, Black, and Hispanic Women |
| https://doi.org/10.3109/13697137.2011.609285 | A guide to the treatment of depression in women by estrogens |
| https://doi.org/10.1080/13697137.2024.2394950 | Menopause and MHT in 2024: addressing the key controversies – an International Menopause Society White Paper |
| https://doi.org/10.3109/09513590.2015.1078303 | May progesterone receptor membrane component 1 (PGRMC1) predict the risk of breast cancer? |
| https://doi.org/10.1016/j.maturitas.2020.04.019 | Managing thromboembolic risk with menopausal hormone therapy and hormonal contraception in the COVID-19 pandemic: Recommendations from the Spanish Menopause Society, Sociedad Española de Ginecología y Obstetricia and Sociedad Española de Trombosis y Hemostasia |
| https://doi.org/10.1172/jci34707 | The estrogen elixir: A history of hormone replacement therapy in America |
| https://doi.org/10.1080/13697137.2020.1820477 | Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence |
| https://doi.org/10.1097/gme.0b013e31828865a5 | Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality |
| https://doi.org/10.3109/13697137.2012.678916 | A decade post WHI, menopausal hormone therapy comes full circle – need for independent commission |
| https://doi.org/10.1016/j.maturitas.2023.04.271 | Reappraising 21 years of the WHI study: Putting the findings in context for clinical practice |
| https://doi.org/10.1038/s41582-025-01071-0 | Alzheimer disease seen through the lens of sex and gender |
| https://doi.org/10.3949/ccjm.91a.23067 | Nonhormone therapies for vasomotor symptom management |
| https://doi.org/10.1016/j.maturitas.2024.107924 | Exercise for peri- and postmenopausal women: Recommendations from synergistic alliances of women's medicine and health psychology for the promotion of an active lifestyle |
| https://doi.org/10.1111/j.1743-6109.2005.20346.x | Assessment and Management of Women's Sexual Dysfunctions: Problematic Desire and Arousal |
| https://doi.org/10.1080/713605136 | Executive summary: Stages of Reproductive Aging Workshop (STRAW) |
| https://doi.org/10.1016/s1526-9523(02)00233-7 | ESTROGEN: PHYSIOLOGY, PHARMACOLOGY, AND FORMULATIONS FOR REPLACEMENT THERAPY |
| https://doi.org/10.3109/09513590.2012.651932 | Reproductive depression |
| https://doi.org/10.1080/01635581.2011.594208 | The Effect of Calcium plus Vitamin D on Risk for Invasive Cancer: Results of the Women's Health Initiative (WHI) Calcium Plus Vitamin D Randomized Clinical Trial |
| https://doi.org/10.3109/13697139809080673 | Climacteric: The Journal of the International Menopause Society |
| https://doi.org/10.1001/jamainternmed.2013.12051 | Obesity and Late-Age Survival Without Major Disease or Disability in Older Women |
| https://doi.org/10.1097/gme.0b013e318068b285 | Oxidative stress, body fat composition, and endocrine status in pre- and postmenopausal women |
| https://doi.org/10.1097/gme.0000000000000553 | Use of compounded hormone therapy in the United States |
| Technological evolution in the radiofrequency treatment of vaginal laxity and menopausal vulvo-vaginal atrophy and other genitourinary symptoms: first experiences with a novel dynamic quadripolar device. | |
| https://doi.org/10.1016/j.maturitas.2019.07.001 | Global Consensus Position Statement on the use of Testosterone Therapy for Women |
| https://doi.org/10.3109/13697137.2012.699563 | The International Menopause Study of Climate, Altitude, Temperature (IMS-CAT) and vasomotor symptoms |
| https://doi.org/10.1016/j.jsxm.2019.07.012 | Global Consensus Position Statement on the Use of Testosterone Therapy for Women |
| https://doi.org/10.1016/j.ics.2004.01.102 | Menopause-related definitions |
| https://doi.org/10.1111/jsm.12702 | Nerve-Sparing Approach Reduces Sexual Dysfunction in Patients Undergoing Laparoscopic Radical Hysterectomy |
| https://doi.org/10.1016/j.cllc.2015.09.004 | Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial |
| https://doi.org/10.1016/j.contraception.2008.10.017 | Profile of the progesterone derivative chlormadinone acetate — Pharmocodynamic properties and therapeutic applications |
| https://doi.org/10.1016/j.amjcard.2019.02.012 | Relation of Pregnancy Loss to Risk of Cardiovascular Disease in Parous Postmenopausal Women (From the Women's Health Initiative) |
| https://doi.org/10.1097/gme.0b013e31826226f2 | A decade after the Women’s Health Initiative—the experts do agree |
| https://doi.org/10.1080/07399332.2019.1578779 | Prevalence and related factors of postpartum depression among reproductive aged women in Ahvaz, Iran |
| https://doi.org/10.1097/01.gme.0000117062.54779.bd | Body mass index does not influence response to treatment, nor does body weight change with lower doses of conjugated estrogens and medroxyprogesterone acetate in early postmenopausal women |
| https://doi.org/10.3109/13625187.2016.1165198 | Prevalence of and risk factors for sexual dysfunction in young Chinese women according to the Female Sexual Function Index: an internet-based survey |
| https://doi.org/10.1097/gme.0000000000001237 | Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years |
| https://doi.org/10.3109/13697137.2015.1115314 | Online education: should we take it seriously? |
| https://doi.org/10.1016/j.fertnstert.2012.05.051 | A decade after the Women's Health Initiative—the experts do agree |
| https://doi.org/10.1097/aog.0000000000001774 | Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative |
| https://doi.org/10.1097/gme.0000000000001049 | Vulvar and vaginal fractional CO2 laser treatments for genitourinary syndrome of menopause |
| https://doi.org/10.3109/13697137.2014.898266 | IMS study of Climate, Altitude, Temperature and vasomotor symptoms in the United Arab Emirates |
| https://doi.org/10.1097/gme.0000000000000996 | Vaginal estrogen in the treatment of genitourinary syndrome of menopause and risk of endometrial cancer: an assessment of recent studies provides reassurance |
| https://doi.org/10.7759/cureus.31228 | Is Erbium/Neodymium Laser Combination Therapy an Effective Treatment Option for Interstitial Cystitis/Bladder Pain Syndrome With Vulvodynia? |
| https://doi.org/10.1016/j.maturitas.2023.02.006 | Menopause and social media: Pros and cons for the general public |
| https://doi.org/10.1590/1806-9282.65.3.292 | Phytotherapeutic medicines: reality or myth? |
| https://doi.org/10.1093/ageing/afy125 | Parental longevity predicts healthy ageing among women |
| https://doi.org/10.31128/ajgp-02-19-4851 | Making choices at menopause |
| https://doi.org/10.1097/gme.0000000000001142 | Not time to abandon use of local vaginal hormone therapies |
| https://doi.org/10.1097/gme.0000000000001828 | Hormone therapy formulation, dose, route of delivery, and risk of hypertension: findings from the Women's Health Initiative Observational Study (WHI-OS) |
| https://doi.org/10.1097/gme.0000000000001313 | Women harmed by vaginal laser for treatment of GSM—the latest casualties of fear and confusion surrounding hormone therapy |
| https://doi.org/10.1111/tog.12848 | Premenstrual disorders including premenstrual syndrome and premenstrual dysphoric disorder |
| https://doi.org/10.1097/gme.0000000000002415 | Menopause and the workplace: consensus recommendations from The Menopause Society |
| https://doi.org/10.1177/20533691231186562 | Menopause in ethnic minority women |
| https://doi.org/10.1097/gme.0000000000000696 | Long-term oral bisphosphonate use in relation to fracture risk in postmenopausal women with breast cancer: findings from the Women's Health Initiative |
| https://doi.org/10.18773/austprescr.2023.014 | Management of menopause |
| https://doi.org/10.1097/gme.0000000000002303 | Prolactinoma in postmenopausal women: a systematic review |
| https://doi.org/10.1080/13696998.2023.2289297 | Evaluating the cost utility of estradiol plus dydrogesterone for the treatment of menopausal women in China |
| https://doi.org/10.1177/2053369120985319 | BMS, RCOG, RCGP, FSRH, FOM and FPH Position Statement in response to the BMA report ‘Challenging the culture on menopause for doctors’ – August 2020 |
| https://doi.org/10.3399/bjgp.2024.0781 | Accessing equitable menopause care in the contemporary NHS: a qualitative study of women's experiences |
| https://doi.org/10.3109/13697137.2012.662252 | Systemic effects of conjugated equine estrogen vaginal cream on bone turnover markers in postmenopausal women |
| https://doi.org/10.3399/bjgp24x739137 | Managing the menopause in general practice: a tale of pragmatism, caution, and optimism |
| https://doi.org/10.1016/j.maturitas.2025.108267 | Quality of life at peri- and postmenopause: analysis of the results from app “Mi Menopausia” |
| https://doi.org/10.1007/s40265-025-02231-8 | Advances in Pharmacotherapy for Menopausal Vasomotor Symptoms |
| https://doi.org/10.1016/j.maturitas.2025.108208 | Eligibility criteria for the use menopausal hormone therapy (MHT) in women with medical conditions (II): Endometriosis, neurological and autoimmune diseases |
| https://doi.org/10.1016/s0950-351x(05)80269-1 | 3 Predictors of menopausal symptoms: psychosocial aspects |
| https://doi.org/10.1016/s0378-5122(02)00016-6 | IGF-1 in gynaecology and obstetrics: update 2002 |
| https://doi.org/10.1097/00042192-200310020-00003 | Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society |
| https://doi.org/10.1097/01.aog.0000254160.62588.41 | Low Dose of Transdermal Estradiol Gel for Treatment of Symptomatic Postmenopausal Women |
| https://doi.org/10.1016/j.accreview.2004.04.052 | Evidence-based guidelines for cardiovascular disease prevention in women |
| https://doi.org/10.1016/j.maturitas.2007.02.021 | Quality of life (QOL) in menopause |
| https://doi.org/10.1258/175404507780456719 | Management of premature menopause |
| https://doi.org/10.5694/j.1326-5377.2009.tb02423.x | The benefits of oestrogen following menopause: why hormone replacement therapy should be offered to postmenopausal women |